pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07041346: The Effect of Gender Education Provided to Health Sciences Students on Gender Perception and Roles

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: EDUCATION

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06360588: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04320888: Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Hematopoietic and Lymphatic System Neoplasm, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma, Recurrent Histiocytic and Dendritic Cell Neoplasm, Recurrent Langerhans Cell Histiocytosis, Recurrent Lymphoma, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Glioma, Recurrent Malignant Solid Neoplasm, Recurrent Medulloblastoma, Recurrent Neuroblastoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Osteosarcoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Rhabdoid Tumor, Recurrent Rhabdomyosarcoma, Recurrent Soft Tissue Sarcoma, Recurrent WHO Grade 2 Glioma, Refractory Ependymoma, Refractory Ewing Sarcoma, Refractory Hepatoblastoma, Refractory Histiocytic and Dendritic Cell Neoplasm, Refractory Langerhans Cell Histiocytosis, Refractory Lymphoma, Refractory Malignant Germ Cell Tumor, Refractory Malignant Glioma, Refractory Malignant Solid Neoplasm, Refractory Medulloblastoma, Refractory Neuroblastoma, Refractory Non-Hodgkin Lymphoma, Refractory Osteosarcoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Rhabdoid Tumor, Refractory Rhabdomyosarcoma, Refractory Soft Tissue Sarcoma, Refractory WHO Grade 2 Glioma, Wilms Tumor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07295288: Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis

Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Synkinesis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07245303: Neural Mechanisms of Light Driven Analgesia

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Musculoskeletal Pain, Fibromyalgia, Healthy Controls Group - Age and Sex-matched

full page →ctgov ↗
›COMPLETEDphase readoutNCT06657261: Comparison of the Analgesic Efficacy of Chest Wall Blocks in Coronary Artery Bypass Surgery

Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Serratus Anterior Muscle Plane Block, Transversus Thoracis Muscle Plane Block, Postoperative Analgesia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07347327: The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke

Sponsor: Ke Dong, MD. Phase: NA. Conditions: Aphasia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05705427: The COMBAT HBV Feasibility Trial

Sponsor: University of North Carolina, Chapel Hill. Phase: PHASE4. Conditions: Hepatitis B, Vertical Transmission of Infectious Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07272486: The Use of Virtual Reality and Music Therapy for Hypertensive Urgency

Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Hypertensive Urgency, Primary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07285642: Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Copd

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368270: Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Diffuse Large B Cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05474170: Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest

Sponsor: Geneve TEAM Ambulances. Phase: NA. Conditions: Cardiopulmonary Arrest, Pediatric ALL, Resuscitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07513870: Comparing Inhalational Anesthesia and TIVA on Maternal and Neonatal Hemodynamics in Elective Cesarean Section

Sponsor: Medipol University. Phase: NA. Conditions: Cesarean Section, Anesthesia, General, Anesthesia, Intravenous

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04963283: Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma, Rectum Cancer, Rectal Cancer, Rectal Adenocarcinoma, Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07311083: Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

Sponsor: Kliniken Essen-Mitte. Phase: NA. Conditions: Microbiome

full page →ctgov ↗
›COMPLETEDphase readoutNCT00506441: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Kidney Disease, Dialysis, Hyperphosphatemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07423741: Ultrasonographical Assessment of Airway Indices in Pregnancy

Sponsor: South Valley University. Phase: . Conditions: Airway Assessment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07181941: Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE1. Conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05478694: Outcomes of Focal Ablation for Prostate Cancer

Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07161466: Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial

Sponsor: Northern Jiangsu People's Hospital. Phase: NA. Conditions: Dynamic Lung Compliance, Alveolar Recruitment Maneuver

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00544466: Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Leukemia, Myelodysplastic Syndromes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07362550: Effects of 12-Week Balanced Diet on Body Composition & Metabolic Parameters in Twins

Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan. Phase: NA. Conditions: Healthy Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT04802291: HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Healthy Lifestyle, Home Environment Related Disease, Cognitive Change, Child Behavior, Child Obesity, Parenting, Parents, Parent-Child Relations

full page →ctgov ↗
›RECRUITINGphase readoutNCT06575374: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cell Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07109297: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

Sponsor: Sanofi. Phase: PHASE4. Conditions: RSV Immunization

full page →ctgov ↗
›RECRUITINGphase readoutNCT07150260: Correlation Between Carotid Stump Pressure and Interhemispheric rSO₂ Asymmetry During Awake Carotid Endarterectomy

Sponsor: Izmir Katip Celebi University. Phase: . Conditions: Carotid Artery Stenosis Symptomatic, Carotid Endarterectomy (CEA) Surgical Patients, Cerebral Hypoperfusion

full page →ctgov ↗
›RECRUITINGphase readoutNCT05903560: Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Sponsor: Jinling Hospital, China. Phase: NA. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07318220: Prehabilitation Protocol for Head and Neck Cancer Patients

Sponsor: University of Miami. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07482020: SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Sponsor: Huashan Hospital. Phase: PHASE2. Conditions: Atrial Fibrillation (AF), Hypertension

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03843359: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04980404: Inqovi Maintenance Therapy in Myeloid Neoplasms

Sponsor: Massachusetts General Hospital. Phase: PHASE1. Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05980884: Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Gut Dysbiosis for TMAO Production From L-carnitine Consumption

full page →ctgov ↗
›COMPLETEDphase readoutNCT02071784: Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: CADASIL

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03839784: Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient

Sponsor: Stanford University. Phase: . Conditions: Cognitive Decline, Cognitive Change, Cognitive Impairment, Postoperative Delirium, Anesthesia; Reaction, Anesthesia; Adverse Effect

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06626633: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06608433: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Healthy Volunteer Study, HPA, Cortisol Deficiency, Adrenal Insufficiency

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07494747: Evaluation of the Effect of the Toothpaste on Delicate Gums

Sponsor: Lacer S.A.. Phase: NA. Conditions: Gingivitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05837949: Multiple Sclerosis Falls Insight Track

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE3. Conditions: Leukemia, MDS

full page →ctgov ↗
›COMPLETEDphase readoutNCT07288658: Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones

Sponsor: University of Waterloo. Phase: PHASE4. Conditions: Limbus Corneae

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02043158: Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227558: Improving Information Sharing Between Family Caregivers and Home Care Aides

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Shared Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07341048: Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Polycythemia, Polycythemia Vera (PV)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06008626: Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Sponsor: Cryosa, Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07139626: Screening of Predictive Biomarkers for Cardiorenal Syndrome

Sponsor: Haiyan Pan. Phase: . Conditions: Cardiorenal Syndrome (CRS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07138885: A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC), Second Line Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03663543: Intravenous Estrogen in Kidney Transplant Study

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Ischemia Reperfusion Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03962543: MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: PHASE2. Conditions: Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT00001215: Genetic Studies of Lysosomal Storage Disorders

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Lysosomal Storage Disorders, Gaucher Disease, Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06572215: DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: Chronic Kidney Diseases

full page →ctgov ↗
← prev
page 70 of 161
next →